EndosQ's research

Coeliac research: Treatment offers hope for normal diet

Gluten is a problem for people with coeliac disease. It isn’t digested properly. Instead of being viewed as a nutrient, the body fights against gluten and this causes problems. Gluten is viewed as an invader and the body fights against it. This means that people with coeliac disease have to modify their diet and avoid any foods that contain gluten, such as wheat, rye or barley and sometimes oats.

Nexvax2 is the only disease-modifying treatment in development that has the potential to help people with coeliac disease return to a normal diet. In Australia, New Zealand and the US, this new vaccine is being tested. This coeliac research is recruiting 84 patients in four sites to test the safety, how tolerable the new vaccine is to patients and how the drug works in the body.

EndosQ is involved in this study. Contact us if you would like to be involved or if you would like to learn more.

Find out more   EndosQ’s research in the media   Contact us

You can find out more in the video below.